Monoclonal antibodies (MAbs) were produced against the asexual blood stages of Plasmodium vivax and Plasmodium ovale and used to define antigens of plasmodial parasites in an indirect fluorescent antibody assay. The anti-P. vivax MAbs produced two distinct patterns in the indirect fluorescent antibody assay. Four patterns were found with the anti-P. ovak MAbs. Species-specific epitopes were defined for P. vivax and P. ovale; epitopes shared among all four species of human malaria parasites were also defined. Some of the anti-P. vivax MAbs reacted only with mature stages, and others reacted with all asexual stages. No asexual blood-stage specificity could be found with the anti-P. ovale antibodies. Five of the anti-P. vivax MAbs and three of the anti-P. ovale MAbs also reacted with sporozoites.
Species-specific, as well as stage-specific, antigens are believed to be important in the development of immunity to malaria parasites. The importance of species-specific immunity has also been demonstrated in studies with monkeys and human volunteers (8, 19) . Infection with one species of parasite does not protect an individual from infection with another species, although it does help to protect against additional infections with the same species. Monoclonal antibodies (MAbs) have been used to identify several stagespecific antigens of Plasmodium falciparum: the major surface glycoprotein (gp195) on merozoites (12) and the circumsporozoite protein on the surface of sporozoites (21) . Both of these antigens are species specific as well as stage specific and consequently have been implicated as targets of protective immunity. In addition, species-specific MAbs would be of particular importance as immunodiagnostic reagents. Plasmodium vivax and Plasmodium ovale have similar morphologies on a Giemsa-stained blood smear, making identification of species difficult, except by the most skilled microscopists. The availability of MAbs that could distinguish between P. vivax and P. ovale would be a great aid in differentiating these two species and would provide tools for epidemiologic and serologic studies in areas where these parasites are transmitted.
The presence of antigens shared between species of malaria parasites is suggested from tests using sera from patients infected with a single species of malaria parasites (23) . Antibodies that react with antigens of other malaria parasite species can be detected in the sera of these patients. Some MAbs produced against P. falciparum have also been shown to react with epitopes on antigens of other Plasmodium species (22) .
To date, laboratory studies of three malaria parasites which infect humans, P. vivax, P. ovale, and P. malariae, have been hampered by the limited availability of parasite material. Although P. falciparum can easily be obtained from in vitro culture, P. vivax, P. ovale, and P. malariae must still be obtained from nonhuman primate and patient blood. To define antigens for these other human malaria parasites and to develop immunodiagnostic reagents, we * Corresponding author.
produced MAbs against the asexual blood stages of P. vivax and P. ovale.
MATERIALS AND METHODS
Hybridoma production. For production of the P. vivaxspecific antibodies, 108 parasites, which were frozen and thawed five times, were used to immunize BALB/cByJ female mice (Jackson Laboratory, Bar Harbor, Maine) three times at 2-week intervals. The first injection was given intraperitoneally with Freund complete adjuvant, the second was given intraperitoneally without adjuvant, and the third was given intravenously in saline. Similarly, the anti-P. ovale hybridomas were produced from a mouse immunized intraperitoneally three times at 2-week intervals, giving the first injection of antigen with Freund complete adjuvant. Six months later, the mice were boosted twice over a 2-week interval, once intraperitoneally and then intravenously. Three days after the last immunization, the spleen cells were removed and fused with a nonsecreting tumor cell line, SP2/0. The cells were plated in 500-microtiter wells in selective media, with 5 x 103 peritoneal exudate cells per well as feeder layers (11) . After 10 to 14 days, supernatants were screened for antibodies reactive with P. vivax or P. ovale by using an indirect fluorescent antibody (IFA) assay. The cell lines producing antibody were then cloned by limiting dilution, again with peritoneal exudate cells as feeder cells. Established clones of each cell line were maintained in the log phase of growth in Opti-MEM medium (GIBCO Laboratories, Grand Island, N.Y.) with 2 to 4% fetal calf serum.
Parasites. Peripheral blood was obtained from chimpanzees infected with either the Chesson strain of P. vivax (10) or the Nigerian I strain of P. ovale (3) . For hybridoma production, the blood was separated by using Percoll gradients to isolate infected erythrocytes and to remove as many leukocytes and uninfected erythrocytes as possible (1) . Slide parasite preparations for IFA were made from washed infected blood spotted onto circles of Teflon-coated slides. Slides for IFA testing were made from blood infected with P. vivax or P. ovale, or other species of parasites. P. malariae Uganda I/CDC (6) was obtained from infected chimpanzee blood, and P. cynomolgi was obtained from rhesus monkeys infected with the Smithsonian, PT-1 (4), or B (P. cynomolgi bastianellii) (14) strain. P. falciparum was obtained from in vitro culture of the Honduras I/CDC, B3 clone (2) .
Strain specificity of the P. vivax MAbs was determined by using two other strains of P. vivax, the ONG (7) and North Korean strains (15) . For examining the stage specificity of the MAbs, blood was obtained from synchronous infections of P. vivax and P. ovale. Blood films were prepared which contained primarily mature stages (schizonts) or primarily ring stages. Sporozoites of P. vivax (Chesson), P. ovale (Nigerian I), P. malariae (Uganda I), and P. falciparum (Honduras, B3) were prepared from infected mosquito salivary glands dissected into 20% fetal calf serum in saline. Sporozoites were allowed to air dry onto wells of the slides.
IFA assay. MAbs were incubated with the parasiteinfected blood films for 30 min at room temperature. The MAbs were then detected with an anti-mouse immunoglobulin G (IgG) (heavy and light chains) (Tago, Inc., Burlingame, Calif.) labeled with fluorescein isothiocyanate (24) . Subclass and isotype determinations were made by using anti-mouse subclass-specific, fluorescein isothiocyanatelabeled antibodies (Litton Bionetics, Charleston, S.C.).
RESULTS
Isotypes and subclasses of MAbs. Seven MAbs produced against P. vivax were of the IgM isotype, and two were IgGl. Three anti-P. vivax MAbs were not tested for isotype or subclass. All of the MAbs produced against P. ovale were IgG; three of these were IgGl, and eight were IgG2a.
IFA patterns. Nine of the anti-P. vivax antibodies produced fluorescence associated with merozoites within mature schizonts (Fig. la) . Three other antibodies produced a pattern of fine dots within the infected erythrocyte, but not associated with the parasite (Fig. lb) . This fluorescence was not produced by using uninfected erythrocytes. Four distinct patterns could be seen by using the anti-P. ovale MAbs. Seven of the antibodies produced a spotted fluorescence pattern within the infected erythrocyte, which was not associated with the parasite (Fig. lc) . Again, this could not be demonstrated by using uninfected erythrocytes. Reaction with the parasite itself was seen with two MAbs, although the fluorescence could not be associated with any distinct organelles or structures within the parasite. An additional antibody produced a diffuse pattern of fluorescence over the entire infected erythrocyte. A similar pattern was produced by another MAb which showed a diffuse fluorescence over the entire cell and also produced fluorescence of the parasite itself (Fig. ld) .
Species and stage specificity. The anti-P. vivax MAbs were classified into two groups according to their reactivity with different asexual blood-stage parasite preparations: those which reacted with mature stages only and those which reacted with mature as well as ring stages (Table 1) . Four anti-P. vivax MAbs reacted with mature stages only, and eight reacted with all asexual blood stages. The species specificity of these MAbs was determined by using blood infected with other malaria parasites. Various combinations of species cross-reactivity were found ( Table 1) . None of the anti-P. vivax MAbs reacted with P. malariae. Of the 12 MAbs, 6 were species specific for P. vivax when tested with the human malaria parasites. Reactivities with a closely related simian parasite, P. cynomolgi, were also found by using three different strains of this parasite: Smithsonian, B, and PT-1 ( Table 2 ). Three MAbs did not react with any of the strains ofP. cynomolgi examined. No strain variability could be demonstrated with the anti-P. vivax MAbs and three strains of P. vivax: Chesson, ONG, and North Korean (data not shown).
The anti-P. ovale MAbs reacted with all asexual blood stages. Species cross-reactions were determined with the other human malaria parasites. Of the 11 antibodies, 7 reacted with all four human malaria parasites. One reacted with only P. vivax and P. falciparum. Three antibodies were species specific and reacted with only P. ovale. At present, only one strain of P. ovale is available, so strain differences could not be examined. 
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To determine if any of the MAbs that were produced against asexual blood stages of the parasites cross-reacted with sporozoite determinants, the MAbs were tested against sporozoites in the IFA assay. Of the 12 anti-P. vivax blood-stage MAbs, 5 reacted with sporozoites of one or more species tested (Table 3) . Five of the anti-P. vivax antibodies reacted with P. vivax sporozoites. One MAb, 103-13.1, reacted with both the blood stages and the sporozoites of P. vivax and P. falciparum. Another MAb, 103-77.2, reacted with only the sporozoites of P. vivax, but did react with the blood stages of P. ovale and P. falciparum. The third MAb, 104-64.9, reacted with the sporozoites and blood stages of only P. vivax. Of the 11 anti-P. ovale blood-stage MAbs, 3 reacted with one or more species of sporozoites. Two reacted with all blood stages as well as sporozoites of all species. One reacted with blood-stage parasites of all species but only with P. vivax and P. malariae sporozoites.
DISCUSSION
MAbs can be used to suggest groupings of antigenic determinants based on stage and species specificities (5, 25) . By using immunofluorescence patterns and stage and species reactivities, we found two types of stage-specific determinants associated with P. vivax: those present on mature stages only and those associated with all asexual stages. By adding the species cross-reactivities, a total of five groups of determinants could be defined. Combining the sporozoite IFA data, three additional groups could be added, resulting in eight distinct specificities determined by the P. vivax MAbs. Similarly, the anti-P. ovale MAbs produced five groups of reactivities determined by species cross-reactions and IFA patterns on the erythrocytic stages of P. ovale. Two additional determinants were defined by adding the sporozoite cross-reactivity data. Although this kind of classification can be used when different patterns of reactivities occur, different epitopes on the same proteins cannot always be distinguished when different patterns are not found. Conversely, it is conceivable that different binding affinities of the MAbs could result in differences in species crossreactions.
Some of the anti-P. vivax MAbs produced an IFA pattern and exhibited stage specificity similar to that associated with antibodies to gp195 of P. falciparum, which is characterized by stage and strain specificity; yet no strain differences could be demonstrated with the anti-P. vivax MAbs. A possible explanation for the lack of strain specificity is the small number of MAbs with stage specificity (four) and the small number of strains examined (three). However, it has been shown by using epitope mapping with MAbs that some epitopes of P. falciparum gp195 are not strain variable (18, 20) . Although the anti-P. vivax merozoite MAbs react with determinants found on merozoites, it is unclear at present if these MAbs are detecting a protein analogous to P. falciparum gp195 or other merozoite antigens.
Stage-specific determinants could not be found with the asexual blood stages of P. ovale and the anti-P. ovale MAbs. Perhaps one reason for this is that the parasite preparations used to immunize the mice contained fewer mature stages than those used in the P. vivax immunizations. It is known from the P. falciparum and P. yoelii systems that stagespecific antigens are often associated with mature parasites (13, 16) . Since these preparations were not used, schizontspecific antibody-secreting clones were not stimulated in these immunized mice.
The presence of shared epitopes on antigens of erythrocytic stages and sporozoites of P. falciparum has been demonstrated (9, 17) . In those studies, a MAb produced against blood-stage parasites was found to react with sporozoites. The antibody defined a determinant on the circumsporozoite protein of P. falciparum sporozoites. Sequence analysis of the blood-stage gene product showed the presence of the same four-amino-acid sequence that is also repeated in the circumsporozoite protein. Although the presence of shared determinants on erythrocytic stages and sporozoites of P. vivax and P. ovale is described in this study, the sporozoite preparations used in these IFA assays were not fixed, allowing reactions with internal as well as surface epitopes. Further analysis is required to determine if the sporozoite cross-reacting MAbs described here detect internal or surface epitopes of the sporozoites.
At this point, it is not possible to say whether the cross-reacting determinants are identical molecules in each species or stage, or whether these molecules would even share the same biological relevance in different stages and species. This cannot be determined until further biochemical and antigenic analyses are performed. These MAbs produced against P. vivax and P. ovale should be useful in defining antigens of importance in both of these species of plasmodia.
VOL. 54, 1986 on September 30, 2017 by guest http://iai.asm.org/ Downloaded from
